Home
Search
Policy

Policy

Insights
Browse all insights
News
Browse all news
BIO Extends Agreement with Avantor for Five Additional Years.
September 17, 2025
BIO's Comments to CDC’s Advisory Committee on Immunization Practices (ACIP)
September 16, 2025
CSBA Letter to Congressional Leaders Supporting SBIR Reauthorization
August 13, 2025
BIO Files Amicus Brief in Case Addressing Anti-Kickback Statute
September 3, 2025
Letters, Comments & Testimony
Browse all Letters, Comments & Testimony
BIO's Comments to CDC’s Advisory Committee on Immunization Practices (ACIP)
September 16, 2025
Re: Docket No. CDC-2025-0454; Advisory Committee on Immunization Practices (ACIP)The Biotechnology Innovation Organization (BIO) is appreciative of the opportunity to provide comments to the Advisory Committee on Immunization Practices (ACIP) in advance of the September 18-19th, 2025 meeting. BIO…
CSBA Letter to Congressional Leaders Supporting SBIR Reauthorization
August 13, 2025
Dear Majority Leader Thune, Minority Leader Schumer, Speaker Johnson, and Minority Leader Jeffries:The Council of State Bioscience Associations (CSBA) is a coalition of independent state and territory based non-profit trade associations, each of which advocates for public policies that support…
CSBA Letter to Congressional Leadership Supporting R&D Tax Expensing Legislation
May 29, 2025
Co-Pay Accumulator Programs
Insurers and PBMs are implementing “co-pay accumulator” programs – an effort to prevent funds provided by manufacturer assistance programs from…
International Reference Pricing
Adopting foreign price controls on innovative medicines would severely chill investment in new cures and therapies for diseases and jeopardize access…